openPR Logo
Press release

Global Molecular Diagnostics Market to reach a market size of $11.2 bn by 2022

03-05-2018 09:39 AM CET | Health & Medicine

Press release from: KBV Research

According to a new report Global Molecular Diagnostics Market (2016-2022), published by KBV Research, the global Molecular Diagnostics is expected to attain a market size of $11.2billion by 2022, growing at a CAGR of 8.6% during the forecast period.

The Reagents & Kits market dominated the Global Molecular Diagnostics Market by Product & Services in 2015, and would continue to be a dominant market till 2022, growing at a Molecular Diagnostics CAGR of 6.7 % during the forecast period. The Instruments market is expected to witness a CAGR of 10.7% during (2016 – 2022). Additionally, The Software & Services market is expected to witness a CAGR of 11.9% during (2016 – 2022).

The Polymerase Chain Reaction market dominated the Global Molecular Diagnostics Market by Technology in 2015, and would continue to be a dominant market till 2022. The Other Technologies market is expected to witness a CAGR of 10.6% during (2016 – 2022). The Isothermal Nucleic Acid Amplification Technology market is expected to witness a CAGR of 9.1% during (2016 – 2022).

The Infectious Diseases market dominated the Global Molecular Diagnostics Market by Application in 2015, and would continue to be a dominant market till 2022. The Other Applications market is expected to witness a CAGR of 12.3% during (2016 – 2022). The Oncology market is expected to witness a CAGR of 9.1% during (2016 – 2022).

The North America market dominated the Global Molecular Diagnostics Market by Region in 2015, and would continue to be a dominant market till 2022; growing at a CAGR of 6.8% during the forecast period. The Europe market is expected to witness a CAGR of 7.8% during (2016 – 2022). Additionally, The Asia-Pacific market is expected to witness a CAGR of 11.4% during (2016 – 2022).

The report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key influencing factors of the global Molecular Diagnosticshave been discussed in the report along with the elaborated company profiles of Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.

Full report : http://kbvresearch.com/global-molecular-diagnostics-market/

Research Scope

Global Molecular Diagnostics Market By Product & Services
Reagents & Kits
Instruments
Software& Services
Global Molecular Diagnostics Market By Technology
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Technology
Hybridization
DNA Sequencing & Next-Generation Sequencing
Microarray
Other Technologies
Global Molecular Diagnostics Market By Application
Infectious Diseases
Chlamydia Trachomatis & Neisseria Gonorrhoea
Hepatitis B & Hepatitis C
Human Papillomavirus
Human Immunodeficiency Virus
Tuberculosis
Methicillin-Resistant Staphylococcus Aurous
Others
Oncology
Breast Cancer
Colorectal Cancer
Prostate Cancer
Other Cancers
Blood Screening
Genetic Tests
Microbiology
Other Applications
Global Molecular Diagnostics Market By End User
Hospital & Academic Laboratories
Reference Laboratories
Other End USers
Global Molecular Diagnostics Market By Geography
North America Molecular Diagnostics Market
U.S Molecular Diagnostics Market
Canada Molecular Diagnostics Market
Mexico Molecular Diagnostics Market
Rest of North America Molecular Diagnostics Market
Europe Molecular Diagnostics Market
Germany Molecular Diagnostics Market
U.K. Molecular Diagnostics Market
France Molecular Diagnostics Market
Russia Molecular Diagnostics Market
Spain Molecular Diagnostics Market
Italy Molecular Diagnostics Market
Rest of EuropeMolecular Diagnostics Market
Asia-Pacific Molecular Diagnostics Market
China Molecular Diagnostics Market
Japan Molecular Diagnostics Market
India Molecular Diagnostics Market
South Korea Molecular Diagnostics Market
Singapore Molecular Diagnostics Market
AustraliaMolecular Diagnostics Market
Rest of Asia-Pacific Molecular Diagnostics Market
LAMEA Molecular Diagnostics Market
Brazil Molecular Diagnostics Market
Argentina Molecular Diagnostics Market
UAE Molecular Diagnostics Market
Saudi Arabia Molecular Diagnostics Market
South Africa Molecular Diagnostics Market
Nigeria Molecular Diagnostics Market
Rest of LAMEA Molecular Diagnostics Market
Companies Profiled
Abbott Laboratories
Qiagen N.V
Roche Diagnostics
Grifols
Siemens Healthcare (Siemens AG)
Becton Dickinson and Company
Danaher Corporation
Unique Offerings from KBV Research
Exhaustive coverage of Global Molecular Diagnostics Market
Highest number of market tables and figures
Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
Subscription based model available
Free of cost quarterly updates
Guaranteed best price
Assured post sales research support with 10% customization free
Related Reports:
North America Molecular Diagnostics Market (2016-2022)

Europe Molecular Diagnostics Market (2016-2022)

Asia Pacific Molecular Diagnostics Market (2016-2022)

LAMEA Molecular Diagnostics Market (2016-2022)

I am digital marketing expert working in research a firm KBV Research
Knowledge Based Value Research is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations.

4F – CS – 27, Ansal Plaza
Sector – 1, Vaishali – 201010
Delhi NCR, Ghaziabad, India
Tel: 0120-4968631 / +91-9990696033
Email: info@kbvresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Molecular Diagnostics Market to reach a market size of $11.2 bn by 2022 here

News-ID: 963697 • Views: 170

More Releases from KBV Research

Push to Talk Market to reach a market size of $43.8 billion by 2025- KBV Researc …
According to a new report Global Push to Talk Market, published by KBV Research, The Global Push to Talk Market size is expected to reach $43.8 billion by 2025, rising at a market growth of 10.1% CAGR during the forecast period. Key factors expected to influence the push-to-talk market growth include increased adoption of push-to-talk over cellular (PoC) in commercial verticals, mass adoption of the mobile-first strategy by pushing vendors
Bakery Processing Equipment Market to reach a market size of $17.9 billion by 20 …
According to a new report Global Bakery Processing Equipment Market, published by KBV Research, The Global Bakery Processing Equipment Market size is expected to reach $17.9 billion by 2025, rising at a market growth of 6.17% CAGR during the forecast period. The ovens and proofers equipment sub-segment held the dominant market share in 2018. In the production of bakery products, ovens and proofers are used to a large extent. Molders and
Caffeinated Beverage Market to reach a market size of $310.5 billion by 2025- KB …
According to a new report Global Caffeinated Beverage Market, published by KBV Research, The Global Caffeinated Beverage Market size is expected to reach $310.5 billion by 2025, rising at a market growth of 6.8% CAGR during the forecast period. The North America market dominated the Global Caffeinated Beverage Market by Region in 2018, thereby, achieving a market value of $123,505.8 million by 2025, growing at a CAGR of 6.1 % during
Acute Hospital Care Market to reach a market size of $3.5 billion by 2025- KBV R …
According to a new report Global Acute Hospital Care Market, published by KBV Research, The Global Acute Hospital Care Market size is expected to reach $3,573.3 billion by 2025, rising at a market growth of 7.04% CAGR during the forecast period. The Emergency Care market dominated the Global Acute Hospital Care Market by Medical Condition in 2018, and would continue to be a dominant market till 2025; thereby, achieving a

All 5 Releases


More Releases for Diagnostics

Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test